Brazilian Research In Intensive Care Network Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04321278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brazilian Research In Intensive Care Network | Brazilian Research in Intensive Care Network (BRICNet)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Coronavirus Infections (Phase 4)

Infections (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Viral (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Severe Acute Respiratory Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8